Given that the superonasal field PIPR amplitude differentiated melanopsin dysfunction in glaucoma suspects from controls, we further compared the superonasal field results with SAP visual fields and OCT (RNFL thickness) used in conventional glaucoma screening and monitoring. The gene discussed is OPN4; the disease is glaucoma.